News Conference News ESC 2014 GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular Caitlin E. Cox September 02, 2014
News Conference News ESC 2014 FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients Yael L. Maxwell September 02, 2014
News Conference News ESC 2014 Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis Caitlin E. Cox August 31, 2014
News Conference News EuroPCR 2014 Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement Caitlin E. Cox May 23, 2014
News Conference News EuroPCR 2014 New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke L.A. McKeown May 23, 2014
News Conference News EuroPCR 2014 UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics Caitlin E. Cox May 22, 2014
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
News Conference News ACC 2014 CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks L.A. McKeown March 31, 2014
News Conference News ACC 2014 TAV-in-BAV: TAVR Achieves Positive Outcomes In Bicuspid Aortic Valve Disease Jason Kahn March 30, 2014
News Conference News ACC 2014 TAVR With the CoreValve Device Superior to Surgery at 1 Year Yael L. Maxwell March 29, 2014
News Conference News ACC 2014 Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR L.A. McKeown March 29, 2014
News Conference News AHA 2013 AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice November 24, 2013
News Conference News TCT 2013 Second-Generation TAVR Device Overcomes Issues of Current Valves October 31, 2013
News Conference News TCT 2013 Opportunities Exist to Improve Outcomes in Transapical TAVR October 29, 2013
News Conference News TCT 2013 Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients October 28, 2013
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk Yael L. Maxwell September 04, 2013
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013
News Conference News ESC 2013 FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk Caitlin E. Cox September 02, 2013
News Conference News AATS 2013 Promising Early Valve-in-Valve Results Seen in Small Nordic Registry L.A. McKeown May 07, 2013